Mycophenolate Mofetil and Steroid for Treatment of Patients With IgA Nephropathy

Mycophenolate Mofetil and Steroid for Treatment of Patients With IgA Nephropathy

Saved in:

Bibliographic Details
Main Authors:	Jing Miao, Parikshit Duriseti, Yeshwanter Radhakrishnan, Lisa Vaughan, Fernando C. Fervenza, Ladan Zand
Format:	Article
Language:	English
Published:	Elsevier 2024-01-01
Series:	Kidney International Reports
Subjects:	IgA nephropathy immunosuppression kidney failure mycophenolate mofetil prednisone steroid
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024923015553
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy and Long-Term Outcomes of Tacrolimus versus Cyclophosphamide and Mycophenolate Mofetil in the Management of Pediatric IgA Vasculitis Nephritis: A Cohort Study in Single-Center
by: Han Y, et al.
Published: (2025-07-01)

Mycophenolate Mofetil and Clostridium difficile-associated Colitis
by: A. I. Dolgushina, et al.
Published: (2021-12-01)

Therapeutic effects of topical Mycophenolate mofetil on hydroquinone-induced depigmentation in Guinea pigs and mice
by: Yuan Guo, et al.
Published: (2025-12-01)

The ability of Mycophenolate Mofetil to induce chromosome aberration and DNA damage in Mus Musculus Mice
by: RUIDA WATHEQ NEAMA, et al.
Published: (2019-12-01)

Cyclophosphamide and mycophenolate mofetil as induction therapy in lupus nephritis
by: Božić-Majstorović Ljubinka, et al.
Published: (2024-01-01)

Low-dose rituximab followed by mycophenolate mofetil for steroid-dependent/frequently relapsing nephrotic syndrome in children: a case series
by: Jide Song, et al.
Published: (2025-08-01)

Indications and Long-Term Outcomes of Using Mycophenolate Mofetil Monotherapy in Substitution for Calcineurin Inhibitors in Liver Transplantation
by: Carlos Jiménez-Romero, et al.
Published: (2025-02-01)

Mycophenolate mofetil versus azathioprine as a first-line treatment for autoimmune hepatitis: a comparative systematic review and meta-analysis
by: Amani M. Ali, et al.
Published: (2025-08-01)

Correlation of segmental sclerosis （S） with podocyte hypertrophy or apical lesions and treatment response IgA nephropathy
by: Tu Yu-chi, et al.
Published: (2022-05-01)

A Case of Repeat Kidney Transplant Intolerant to Multiple First-line Immunosuppressive Agents Mycophenolate Mofetil, Azathioprine, and Calcineurin Inhibitors
by: Puneet Arora, et al.
Published: (2024-12-01)

Comparative efficacy and safety of mycophenolate mofetil and azathioprine in combination with corticosteroids in the treatment of lymphocytic myocarditis
by: R. S. Rud, et al.
Published: (2021-12-01)

Tacrolimus and mycophenolate mofetil in corticosteroid-resistant hepatitis secondary to tislelizumab: a case report
by: Chang Jiang, et al.
Published: (2025-02-01)

Effect of tacrolimus with mycophenolate mofetil or cyclophosphamide on the renal response in systemic lupus erythematosus patients
by: Siqin Sun, et al.
Published: (2024-12-01)

STUDY OF THE EFFICIENCY AND SAFETY OF MYCOPHENOLATE MOFETIL THERAPY IN PATIENTSWITH SYSTEMIC SCLERODERMA
by: O A Koneva, et al.
Published: (2011-08-01)

Mycophenolate mofetil: an update on its mechanism of action and effect on lymphoid tissue
by: Anna Krawczyk, et al.
Published: (2025-01-01)

Optimization of Xanthan Gum and Sorbitol Levels in the Mycophenolate Mofetil Powder for Oral Suspension
by: Amin Umrani, et al.
Published: (2023-01-01)

Successful Long-Term Treatment of Pediatric Relapsing Idiopathic Optic Neuritis with Mycophenolate Mofetil
by: Shuhei Fujino, et al.
Published: (2025-03-01)

Mycophenolate Mofetil in the Management of Oral Mucocutaneous Diseases: Current Evidence and Future Perspectives
by: Khalid Aljohani, et al.
Published: (2025-05-01)

Mycophenolate mofetil vs. cyclophosphamide-based induction regimens for lupus nephritis: outcomes at a tertiary care centre in Lahore, Pakistan
by: Muhammad Ahmed Saeed, et al.
Published: (2024-04-01)

Analysis on effects of different treatment regimens for patients with IgA nephropathy
by: ZHU Ming-zhi, et al.
Published: (2019-01-01)

Effect of leflunomide combined with small-dose prednisone on the clinical efficacy of IgA nephropathy, renal functions and urine proteins
by: YANG Yan-ping, et al.
Published: (2019-01-01)

Mycophenolate mofetil versus cyclophosphamide, in combination with prednisolone for lupus nephritis induction treatment: Findings from a prospective observational study
by: Rakhesh LR, et al.
Published: (2025-07-01)

Mycophenolic acid trough level assessment in patients with lupus nephritis; does it make a difference?
by: Ahmed E. Abdulgalil, et al.
Published: (2025-03-01)

Cleft Palate Induced by Mycophenolate Mofetil Is Associated with <i>miR-4680-3p</i> and <i>let-7c-5p</i> in Human Palate Cells
by: Hiroki Yoshioka, et al.
Published: (2025-02-01)

Recent advances on non-immunosuppressive treatment of IgA nephropathy
by: Ding Wan, et al.
Published: (2025-07-01)

Comparative Study of Mycophenolate Mofetil and Methotrexate in Graft-Versus-Host Disease Prophylaxis in Adult Recipients of Related and Unrelated Allo-HSCT
by: IS Moiseev, et al.
Published: (2018-12-01)

Efficacy of mycophenolate mofetil for the maintenance therapy of anti-AQP4 antibody-positive NMOSD complying with probable sjögren’s disease in a 2-year-old girl: a case report
by: Takeshi Yamamoto, et al.
Published: (2025-07-01)

<i>Sasa veitchii</i> Extract Mitigates Mycophenolate Mofetil-Induced Human Palatal Cell Proliferation Inhibition by Downregulating <i>microRNA-4680-3p</i>
by: Hanane Horita, et al.
Published: (2025-04-01)

Effect of Telitacicept on Circulating Gd-IgA1 and IgA-Containing Immune Complexes in IgA Nephropathy
by: Jincan Zan, et al.
Published: (2024-04-01)

Mycophenolate mofetil after tacrolimus for refractory clinically amyopathic dermatomyositis: a case report
by: Gui-Chen Ling, et al.
Published: (2024-10-01)

Effectiveness of myocarditis therapy depending on the diagnosis approach (with or without myocardial biopsy)
by: O. V. Blagova, et al.
Published: (2021-05-01)

IgA Nephropathy Associated with IgA Vasculitis Coexisting with Focal Segmental Glomerulosclerosis Tip Variant
by: Zitlali Guadalupe Paulín Zepeda, et al.
Published: (2023-07-01)

Current status of clinical studies of IgA nephropathy with minimal proteinuria
by: SHI Yu-zhen, et al.
Published: (2020-01-01)

Serum IgA/C3 ratio as a diagnostic and prognostic biomarker for IgA nephropathy
by: Anitha Swamy, et al.
Published: (2025-08-01)

Significance of serum IgA/C3 ratio in the diagnosis and prognosis of IgA nephropathy
by: XIE Wei-ji, et al.
Published: (2019-01-01)

Association between tonsillectomy plus steroid pulse therapy and renal outcomes in patients with IgA nephropathy: a retrospective cohort study
by: Ayano Hayashi, et al.
Published: (2025-08-01)

COVID-19 Pneumonia in Patients with Chronic Myocarditis (HBV-Associated with InfarctLike Debute): Specifics of the Diseases Course, the Role of the Basic Therapy (Part II)
by: O. V. Blagova, et al.
Published: (2020-11-01)

Study on the relationship between plasma Gd-IgA1 concentration and disease severity in IgA nephropathy and its production mechanism
by: DAI Qin, et al.
Published: (2020-01-01)

Predictive value of sub classification of focal segmental glomerular sclerosis in Oxford classification of IgA nephropathy
by: Fang Yu, et al.
Published: (2021-01-01)

Mycophenolate mofetil combined with steroids: New experiences in the treatment of idiopathic retroperitoneal fibrosis
by: Obrenčević Katarina, et al.
Published: (2007-01-01)